Rituximab/bendamustine/cytarabine for transplant‐eligible patients with mantle cell lymphoma: A retrospective study

BACKGROUND: Mantle cell lymphoma is considered an aggressive B‐cell lymphoma. The optimal induction regimen remains controversial as no randomized controlled trial has compared the efficacy of different induction therapies. METHOD: Herein, we performed a retrospective analysis of the clinical charac...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimizu, Yuki, Kaji, Daisuke, Watanabe, Otoya, Yamaguchi, Kyosuke, Kageyama, Kosei, Taya, Yuki, Nishida, Aya, Ishiwata, Kazuya, Takagi, Shinsuke, Yamamoto, Hisashi, Mori, Yuki‐Asano, Wake, Atsushi, Uchida, Naoyuki, Taniguchi, Shuichi, Yamamoto, Go
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
BRIEF COMMUNICATION
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278520/
https://www.ncbi.nlm.nih.gov/pubmed/37199050
http://dx.doi.org/10.1002/cam4.6114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278520/
https://www.ncbi.nlm.nih.gov/pubmed/37199050
http://dx.doi.org/10.1002/cam4.6114

Ejemplares similares